Axsome Therapeutics stock is up 16% year to date. Why Wall Street thinks it has even more room to run The Motley Fool 11h Wall Street Stock Markets (World) Stock Market (US)
European regulators recall Amgen’s rare disease drug Tavneos BioWorld 3d Rare Diseases Biotech Article paywall
Moderna’s 177% surge: Buy, sell or hold after the breakout? Investing.com UK 4d Coronavirus Vaccine Moderna Vaccine Pharma
AstraZeneca maintains Citi 'buy' rating despite mixed pipeline updates Proactive Investors (UK) 6d Stock Markets (World) FTSE 100 Stock Market
AstraZeneca ditches lung cancer treatment trial Evening Standard 7d Lung Cancer FTSE 100 Cancer Treatment Article paywall
Orpathys plus Tagrisso shows survival benefit in lung cancer PharmaTimes 5d AstraZeneca FTSE 100 Pharma All sources
DESTINY-Lung04: First-line trastuzumab deruxtecan improves PFS in NSCLC Pulmonology Advisor 5d Cancer Treatment Cancer NSCLC
Lung cancer risk comparable in screening-negative vs low-risk patients Pulmonology Advisor 6d Cancer Global Health
AstraZeneca halts key lung cancer trial after setback Times LIVE 7d AstraZeneca Pharma Article paywall
Berries and nuts may reverse life-threatening damage caused by heart failure MailOnline 1d Heart Disease Global Health Article paywall All sources
Fastest star ever found zips around Milky Way’s black hole To Vima 2d Milky Way Black Holes Astronomy All sources
mRNA therapy found to prevent recurrence of melanoma LabOnline 3d mRNA Cancer Treatment Cancer All sources
China delays Chang’e-7 lunar South pole landing mission launch SpaceNews 16h The Moon Space Exploration China All sources
